United States· US:70518-4681_54ebc3d5-af75-9ff5-e063-6294a90a95e5
E.E.S
A medicinal product containing erythromycin ethylsuccinate, registered in United States by REMEDYREPACK INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ERYTHROMYCIN ETHYLSUCCINATE
- Manufacturer
- REMEDYREPACK INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1170518-4681-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Erythromycin ethylsuccinate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomErythromycin ethyl succinate 125mg/5ml oral suspensionKent Pharma (UK) Ltd
- FinlandAbboticinAbbott Scandinavia AB
- BelgiumErythrocine 250 mg/5 mlAmdipharm
- IrelandPrimacine 125 mg/5 ml Granules for Oral SuspensionPinewood Laboratories Ltd
- GermanyErythrocin NeoAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Erythroforte
- Germany · Erythrocin Neo
- Denmark · Abboticin, Abboticin Novum
- Spain · Eritromicina Normon, Pantomicina
- France · Ery Enfants, Erythrocine
- United Kingdom (Northern Ireland) · Erythromycin, Erythromycin Amdipharm Uk
- Ireland · Erythroped, Erythroped Pi
- Luxembourg · Erythrocine, Erythroforte
- Malta · Primacine
- Norway · Abboticin Es
- Portugal · E.S.E. 500, Eritrocina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c518310c-68a2-48a3-aee6-a6348fede674 GET /v1/drugs/c518310c-68a2-48a3-aee6-a6348fede674?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "400",
"substance": "ERYTHROMYCIN ETHYLSUCCINATE",
"productndc": "70518-4681",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA061905",
"marketing_category": "ANDA"
}See everything about erythromycin ethylsuccinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.